Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Circelli L, Sciammarella C, Guadagno E, Tafuto S, del Basso de Caro M, Botti G, Pezzullo L, Aria M, Ramundo V, Tatangelo F, Losito NS, Ieranò C, D'Alterio C, Izzo F, Ciliberto G, Colao A, Faggiano A, Scala S. Circelli L, et al. Among authors: ramundo v. Oncotarget. 2016 Apr 5;7(14):18865-75. doi: 10.18632/oncotarget.7738. Oncotarget. 2016. PMID: 26934559 Free PMC article.
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Circelli L, Ramundo V, Marotta V, Sciammarella C, Marciello F, Del Prete M, Sabatino L, Pasquali D, Izzo F, Scala S, Colao A, Faggiano A, Colantuoni V; Multidisciplinary Group for NeuroEndocrine Tumours of Naples. Circelli L, et al. Among authors: ramundo v. J Cell Mol Med. 2015 Jul;19(7):1735-41. doi: 10.1111/jcmm.12552. Epub 2015 Mar 30. J Cell Mol Med. 2015. PMID: 25824098 Free PMC article.
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours.
Ramundo V, Del Prete M, Marotta V, Marciello F, Camera L, Napolitano V, De Luca L, Circelli L, Colantuoni V, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A; Multidisciplinary Group for Neuroendocrine Tumors of Naples. Ramundo V, et al. Clin Endocrinol (Oxf). 2014 Jun;80(6):850-5. doi: 10.1111/cen.12411. Epub 2014 Feb 19. Clin Endocrinol (Oxf). 2014. PMID: 24443791
Hepatic arterial embolization in patients with neuroendocrine tumors.
Del Prete M, Fiore F, Modica R, Marotta V, Marciello F, Ramundo V, Di Sarno A, Carratù A, di Roseto Cde L, Tafuto S, Tatangelo F, Baldelli R, Colao A, Faggiano A; Multidisciplinary Group for NeuroEndocrine Tumors of Naples. Del Prete M, et al. Among authors: ramundo v. J Exp Clin Cancer Res. 2014 May 19;33(1):43. doi: 10.1186/1756-9966-33-43. J Exp Clin Cancer Res. 2014. PMID: 24887262 Free PMC article. Review.
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
Marotta V, Franzese MD, Del Prete M, Chiofalo MG, Ramundo V, Esposito R, Marciello F, Pezzullo L, Carratù A, Vitale M, Colao A, Faggiano A. Marotta V, et al. Among authors: ramundo v. Expert Opin Pharmacother. 2013 Jun;14(9):1187-203. doi: 10.1517/14656566.2013.796931. Expert Opin Pharmacother. 2013. PMID: 23675883 Review.
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
Fiore F, Del Prete M, Franco R, Marotta V, Ramundo V, Marciello F, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A. Fiore F, et al. Among authors: ramundo v. Endocrine. 2014 Sep;47(1):177-82. doi: 10.1007/s12020-013-0130-9. Epub 2014 Jan 3. Endocrine. 2014. PMID: 24385266
62 results